Download the list of Controlled Drugs as per the Irish regulation: (446KB) The Misuse of Drugs Regulations 1988 (as amended) regulate controlled drugs in Ireland. A controlled drug (CD) is any substance, product or preparation specified in the schedules of the Misuse of Drugs Regulations. CDs are divided into five schedules according to their potential for misuse […]
New classification criteria for rheumatoid arthritis
August 5, 2011 by Leave a Comment
Recently an American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) task force developed new classification criteria for rheumatoid arthritis (RA).1 Download Score Calculation: PDF (423KB) Early diagnosis is important to prevent joint damage and functional impairment by early treatment. However, the previous classification criteria for RA (the 1987 ACR criteria) proved inadequate in the early […]
New Data on Predictors of Knee Arthritis Progression
August 5, 2011 by Leave a Comment
New results of a review including 30 studies designed to identify patient characteristics that can be used by health care practitioners to predict likelihood of knee osteoarthritis (OA) progression. The review, including 30 studies, found that relatively few variables are strong predictors of knee OA progression (see table). Patient characteristics that predict progression of knee […]
Approved Biologic Therapies in Rheumatoid Arthritis
August 5, 2011 by Leave a Comment
Approved Biologic Therapies in Rheumatoid Arthritis Show Further Evidence of Efficacy and Reduction in Joint Damage at EULAR 2011 PDF (746KB) One of the major annual rheumatology conferences, the European League Against Rheumatism’s Congress (EULAR), year had this year’s programme dominated by approved biologics in rheumatoid arthritis (RA), comprising roughly 25% of clinical trial abstracts […]
New Combination Vimovo shown to reduce gastric ulcer incidences
August 5, 2011 by Leave a Comment
PDF (764KB) AstraZeneca is pleased to announce the introduction of Vimovo, the only NSAID/PPI combination tablet offering proven NSAID pain relief with a built-in PPI. Each modified-release Vimovo tablet contains 500mg enteric-coated (gastro-resistant) naproxen and 20mg film-coated esomeprazole (as magnesium trihydrate). Vimovo is indicated for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, […]
Gardasil – Overview of National Monitoring Experience
August 5, 2011 by Leave a Comment
The HSE human papillomavirus (HPV) Schools Immunisation Programme commenced in May 2010 and recently completed its first year. It is estimated that over 159,000 doses of Gardasil have been distributed, with at least 145,000 doses administered up to June 2011 as part of the programme. No new risks have been identified for Gardasil during monitoring […]
Eirfem
August 1, 2011 by Leave a Comment
Company: Niche Generics Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Letrozole 2.5mg. Description: Yellow, round, biconvex, film-coated, tablets marked 2.5 on one side. Presentation: 30, €42.25. Indications: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. Extended adjuvant treatment of hormone-dependent early breast cancer in postmenopausal women who have received […]
Letrozole
August 1, 2011 by Leave a Comment
Company: Clonmel Healthcare. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Letrozole 2.5mg. Description: Yellow, round, biconvex film-coated tablets. Presentation: 30, €42.25. Indications: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. Extended adjuvant treatment of hormone dependent early breast cancer in postmenopausal women who have received prior standard adjuvant tamoxifen therapy […]
Letzo
August 1, 2011 by Leave a Comment
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Letrozole 2.5mg Description: Dark yellow, round, biconvex film-coated tablets marked FV on one side, CG on the other. Presentation: 30, €52.82. Indications: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. Extended adjuvant treatment of hormone dependent early breast cancer in […]
Ramipril Niche
August 1, 2011 by Leave a Comment
Company: Niche Generics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Ramipril 1.25mg, 2.5mg, 5mg, 10mg. Description: 1.25mg: White circular biconvex tablets with B embossed on one side and 48 on the other. 2.5mg: Light yellow capsule-shaped, biconvex tablets with a score line on one side and B and 49 embossed either side of […]
Loading ...
